UPSA
France
Dr. Rassa Pegahi holds a Ph.D. in Molecular and Cell Biology and has gained extensive experience in oncology through years of hands-on work in a hospital setting. Since 2012, she has been developing strong expertise in the pharmaceutical industry and is currently pursuing her career as a senior specialist in medical affairs and clinical trials.
5 Previous Presentations
The common cold is the most frequent upper respiratory viral infection. Although benign, it represents a high socioeconomic burden. Many over-the-counter drugs are available to…
Background and Aim: Effective analgesia and fever management in children from birth remain crucial. This study aims to provide updated insights into the use of paracetamol in…
Background: Paracetamol is effective and safe in mild to moderate migraine attacks and episodes of tension-type headache (TTH). Few data are available on the use of paracetamol…
Paracetamol remains the recommended first-line option for mild-to-moderate acute pain in general population and particularly in vulnerable populations. Despite its wide use…
Paracetamol remains the recommended first-line option for mild-to-moderate acute pain in general population and particularly in vulnerable populations. Despite its wide use…
Valencia · September 13–15, 2027 · Hybrid · in-person & virtual
Attend without presenting.
